Branched-chain amino acids in liver diseases

World Journal of Gastroenterology

Volumn 19, Issue 43, 2013, Pages 7620-7629

  Tajiri, Kazuto ^a   Shimizu, Yukihiro ^b  

^a TOYAMA UNIVERSITY HOSPITAL   (Japan)

^b Nanto Municipal Hospital   (Japan)

Author keywords

Branched chain amino acids; Gene expression; Hepatocyte apoptosis; Hepatocyte regeneration; Immunity; Liver disease; Treatment

Indexed keywords

ALBUMIN; BRANCHED CHAIN AMINO ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE 6 PHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; MAMMALIAN TARGET OF RAPAMYCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENYLALANINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TYROSINE; VASCULOTROPIN;

ALCOHOL LIVER DISEASE; APOPTOSIS; CELL PROLIFERATION; CHEMOEMBOLIZATION; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DNA REPAIR; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; INSULIN RESISTANCE; LIPOLYSIS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER INJURY; LIVER RESECTION; LIVER TRANSPLANTATION; MULTICENTER STUDY (TOPIC); NONALCOHOLIC FATTY LIVER; NONHUMAN; PROGRESSION FREE SURVIVAL; PROTEIN DEFICIENCY; PROTEIN METABOLISM; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR;

BRANCHED CHAIN AMINO ACIDS; GENE EXPRESSION; HEPATOCYTE APOPTOSIS; HEPATOCYTE REGENERATION; IMMUNITY; LIVER DISEASE; TREATMENT;

AMINO ACIDS, BRANCHED-CHAIN; BIOLOGICAL MARKERS; CHRONIC DISEASE; DIETARY SUPPLEMENTS; HUMANS; LIVER; LIVER DISEASES; TREATMENT OUTCOME;

EID: 84888088346     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i43.7620     Document Type: Review

References (106)

1. Campollo O, Sprengers D, McIntyre N. The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics. Rev Invest Clin 1992; 44: 513-518 [PMID: 1485030]
2. Steigmann F, Szanto PB, Poulos A, Lim PE, Dubin A. Significance of serum aminograms in diagnosis and prognosis of liver diseases. J Clin Gastroenterol 1984; 6: 453-460 [PMID: 6501833]
3. Watanabe A, Higashi T, Sakata T, Nagashima H. Serum amino acid levels in patients with hepatocellular carcinoma. Cancer 1984; 54: 1875-1882 [PMID: 6090002]
4. Suzuki K, Suzuki K, Koizumi K, Ichimura H, Oka S, Takada H, Kuwayama H. Measurement of serum branched-chain amino acids to tyrosine ratio level is useful in a prediction of a change of serum albumin level in chronic liver disease. Hepatol Res 2008; 38: 267-272 [PMID: 18021234]
5. D'Antona G, Ragni M, Cardile A, Tedesco L, Dossena M, Bruttini F, Caliaro F, Corsetti G, Bottinelli R, Carruba MO, Valerio A, Nisoli E. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab 2010; 12: 362-372 [PMID: 20889128 DOI: 10.1016/ j.cmet.2010.08.016]
6. Ichikawa K, Okabayashi T, Shima Y, Iiyama T, Takezaki Y, Munekage M, Namikawa T, Sugimoto T, Kobayashi M, Mimura T, Hanazaki K. Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride. Mol Biol Rep 2012; 39: 10803-10810 [PMID: 23053977 DOI: 10.1007/ s11033-012-1974-4]
7. Nishitani S, Ijichi C, Takehana K, Fujitani S, Sonaka I. Pharmacological activities of branched-chain amino acids: specificity of tissue and signal transduction. Biochem Biophys Res Commun 2004; 313: 387-389 [PMID: 14684173]
8. Schieke SM, Phillips D, McCoy JP, Aponte AM, Shen RF, Balaban RS, Finkel T. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 2006; 281: 27643-27652 [PMID: 16847060]
9. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007; 450: 736-740 [PMID: 18046414]
10. Arakawa M, Masaki T, Nishimura J, Seike M, Yoshimatsu H. The effects of branched-chain amino acid granules on the accumulation of tissue triglycerides and uncoupling proteins in diet-induced obese mice. Endocr J 2011; 58: 161-170 [PMID: 21372430]
11. Kuwahata M, Kubota H, Kanouchi H, Ito S, Ogawa A, Kobayashi Y, Kido Y. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease. Nutr Res 2012; 32: 522-529 [PMID: 22901560 DOI: 10.1016/j.nutres.2012.06.007]
12. Kim SJ, Kim DG, Lee MD. Effects of branched-chain amino acid infusions on liver regeneration and plasma amino acid patterns in partially hepatectomized rats. Hepatogastroenterology 2011; 58: 1280-1285 [PMID: 21937393]
13. Tomiya T, Omata M, Fujiwara K. Significance of branched chain amino acids as possible stimulators of hepatocyte growth factor. Biochem Biophys Res Commun 2004; 313: 411-416 [PMID: 14684177 DOI: 10.1016/j.bbrc.2003.07.017]
14. Okuno M, Moriwaki H, Kato M, Muto Y, Kojima S. Changes in the ratio of branched-chain to aromatic amino acids affect the secretion of albumin in cultured rat hepatocytes. Biochem Biophys Res Commun 1995; 214: 1045-1050 [PMID: 7575508 DOI: 10.1006/bbrc.1995.2391]
15. Ijichi C, Matsumura T, Tsuji T, Eto Y. Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun 2003; 303: 59-64 [PMID: 12646166 DOI: 10.1016/S0006-291X(03)00295-X]
16. Montoya A, Gómez-Lechón MJ, Castell JV. Influence of branched-chain amino acid composition of culture media on the synthesis of plasma proteins by serum-free cultured rat hepatocytes. In Vitro Cell Dev Biol 1989; 25: 358-364 [PMID: 2715129 DOI: 10.1007/BF02624599]
17. Kuwahata M, Yoshimura T, Sawai Y, Amano S, Tomoe Y, Segawa H, Tatsumi S, Ito M, Ishizaki S, Ijichi C, Sonaka I, Oka T, Miyamoto K. Localization of polypyrimidine-tractbinding protein is involved in the regulation of albumin synthesis by branched-chain amino acids in HepG2 cells. J Nutr Biochem 2008; 19: 438-447 [PMID: 17707630 DOI: 10.1016/ j.jnutbio.2007.05.011]
18. Kawaguchi T, Nagao Y, Matsuoka H, Ide T, Sata M. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int J Mol Med 2008; 22: 105-112 [PMID: 18575782]
19. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, Hutson SM. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab 2007; 6: 181-194 [PMID: 17767905 DOI: 10.1016/j.cmet.2007.08.003]
20. Ikehara O, Kawasaki N, Maezono K, Komatsu M, Konishi A. Acute and chronic treatment of L-isoleucine ameliorates glucose metabolism in glucose-intolerant and diabetic mice. Biol Pharm Bull 2008; 31: 469-472 [PMID: 18310912 DOI: 10.1248/ bpb.31.469]
21. Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007; 56: 1647-1654 [PMID: 17360978 DOI: 10.2337/db07-0123]
22. Zhang Y, Kobayashi H, Mawatari K, Sato J, Bajotto G, Kitaura Y, Shimomura Y. Effects of branched-chain amino acid supplementation on plasma concentrations of free amino acids, insulin, and energy substrates in young men. J Nutr Sci Vitaminol (Tokyo) 2011; 57: 114-117 [PMID: 21512300 DOI: 10.3177/jnsv.57.114]
23. Higuchi N, Kato M, Miyazaki M, Tanaka M, Kohjima M, Ito T, Nakamuta M, Enjoji M, Kotoh K, Takayanagi R. Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver. J Cell Biochem 2011; 112: 30-38 [PMID: 20506195 DOI: 10.1002/jcb.22688]
24. Hinault C, Mothe-Satney I, Gautier N, Lawrence JC, Van Obberghen E. Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db/db mice. FASEB J 2004; 18: 1894-1896 [PMID: 15479767]
25. Nishitani S, Matsumura T, Fujitani S, Sonaka I, Miura Y, Yagasaki K. Leucine promotes glucose uptake in skeletal muscles of rats. Biochem Biophys Res Commun 2002; 299: 693-696 [PMID: 12470633 DOI: 10.1016/S0006-291X(02)02717-1]
26. Sugiyama K, Yu L, Nagasue N. Direct effect of branchedchain amino acids on the growth and metabolism of cultured human hepatocellular carcinoma cells. Nutr Cancer 1998; 31: 62-68 [PMID: 9682250 DOI: 10.1080/01635589809514679]
27. Miuma S, Ichikawa T, Arima K, Takeshita S, Muraoka T, Matsuzaki T, Ootani M, Shibata H, Akiyama M, Ozawa E, Miyaaki H, Taura N, Takeshima F, Nakao K. Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells. J Cell Biochem 2012; 113: 3113-3121 [PMID: 22581719 DOI: 10.1002/jcb.24188]
28. Hagiwara A, Nishiyama M, Ishizaki S. Branched-chain amino acids prevent insulin-induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2-dependent mechanisms. J Cell Physiol 2012; 227: 2097-2105 [PMID: 21769869 DOI: 10.1002/jcp.22941]
29. Ninomiya S, Shimizu M, Imai K, Takai K, Shiraki M, Hara T, Tsurumi H, Ishizaki S, Moriwaki H. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells. Cancer Prev Res (Phila) 2011; 4: 2092-2100 [PMID: 21952585 DOI: 10.1158/1940-6207.CAPR-11-0340]
30. Formisano P, Oriente F, Fiory F, Caruso M, Miele C, Maitan MA, Andreozzi F, Vigliotta G, Condorelli G, Beguinot F. Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Mol Cell Biol 2000; 20: 6323-6333 [PMID: 10938109 DOI: 10.1128/MCB.20.17.6323-6333.2000]
31. Iwasa J, Shimizu M, Shiraki M, Shirakami Y, Sakai H, Terakura Y, Takai K, Tsurumi H, Tanaka T, Moriwaki H. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Sci 2010; 101: 460-467 [PMID: 19906067 DOI: 10.1111/ j.1349-7006.2009.01402.x]
32. Yoshiji H, Noguchi R, Kaji K, Ikenaka Y, Shirai Y, Namisaki T, Kitade M, Tsujimoto T, Kawaratani H, Fukui H. Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats. J Gastroenterol 2010; 45: 443-450 [PMID: 19941011 DOI: 10.1007/s00535-009-0158-z]
33. Chuang JC, Yu CL, Wang SR. Modulation of lymphocyte proliferation by enzymes that degrade amino acids. Clin Exp Immunol 1990; 82: 469-472 [PMID: 2124955]
34. Tsukishiro T, Shimizu Y, Higuchi K, Watanabe A. Effect of branched-chain amino acids on the composition and cytolytic activity of liver-associated lymphocytes in rats. J Gastroenterol Hepatol 2000; 15: 849-859 [PMID: 11022824 DOI: 10.1046/j.1440-1746.2000.02220.x]
35. Kakazu E, Kanno N, Ueno Y, Shimosegawa T. Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells. J Immunol 2007; 179: 7137-7146 [PMID: 17982106]
36. Kakazu E, Ueno Y, Kondo Y, Fukushima K, Shiina M, Inoue J, Tamai K, Ninomiya M, Shimosegawa T. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis. Hepatology 2009; 50: 1936-1945 [PMID: 19885880 DOI: 10.1002/hep.23248]
37. Nakamura I, Ochiai K, Imai Y, Moriyasu F, Imawari M. Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients. Hepatol Res 2007; 37: 1062-1067 [PMID: 17608669 DOI: 10.1111/j.1872-034X.2007.00166.x]
38. Nuwer N, Cerra FB, Shronts EP, Lysne J, Teasley KM, Konstantinides FN. Does modified amino acid total parenteral nutrition alter immune-response in high level surgical stress. JPEN J Parenter Enteral Nutr 1983; 7: 521-524 [PMID: 6418905 DOI: 10.1177/0148607183007006521]
39. Cerra FB, Mazuski JE, Chute E, Nuwer N, Teasley K, Lysne J, Shronts EP, Konstantinides FN. Branched chain metabolic support. A prospective, randomized, double-blind trial in surgical stress. Ann Surg 1984; 199: 286-291 [PMID: 6422868 DOI: 10.1097/00000658-198403000-00007]
40. De Bandt JP, Cynober L. Therapeutic use of branched-chain amino acids in burn, trauma, and sepsis. J Nutr 2006; 136: 308S-313S [PMID: 16365104]
41. Charlton MR. Protein metabolism and liver disease. Baillieres Clin Endocrinol Metab 1996; 10: 617-635 [PMID: 9022955 DOI: 10.1016/S0950-351X(96)80771-3]
42. Miwa Y, Moriwaki H. Nocturnal energy and BCAA supplementation in patients with liver cirrhosis. Hepatol Res 2004; 30S: 63-66 [PMID: 15607141 DOI: 10.1016/ j.hepres.2004.08.012]
43. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H. Effects of oral branched-chain amino acid granules on eventfree survival in patients with liver cirrhosis. Clin Gastroen-terol Hepatol 2005; 3: 705-713 [PMID: 16206505 DOI: 10.1016/ S1542-3565(05)00017-0]
44. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Rossi Fanelli F, Abbiati R. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003; 124: 1792-1801 [PMID: 12806613 DOI: 10.1016/ S0016-5085(03)00323-8]
45. Sato S, Watanabe A, Muto Y, Suzuki K, Kato A, Moriwaki H, Kato M, Nakamura T. Clinical comparison of branchedchain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study). Hepatol Res 2005; 31: 232-240 [PMID: 15792640 DOI: 10.1016/ j.hepres.2005.01.009]
46. Habu D, Nishiguchi S, Nakatani S, Lee C, Enomoto M, Tamori A, Takeda T, Ohfuji S, Fukushima W, Tanaka T, Kawamura E, Shiomi S. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis. Hepatogastroenterology 2009; 56: 1719-1723 [PMID: 20214224]
47. Koreeda C, Seki T, Okazaki K, Ha-Kawa SK, Sawada S. Effects of late evening snack including branched-chain amino acid on the function of hepatic parenchymal cells in patients with liver cirrhosis. Hepatol Res 2011; 41: 417-422 [PMID: 21518402 DOI: 10.1111/j.1872-034X.2011.00795.x]
48. Habu D, Nishiguchi S, Nakatani S, Kawamura E, Lee C, Enomoto M, Tamori A, Takeda T, Tanaka T, Shiomi S. Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial. Hepatol Res 2003; 25: 312-318 [PMID: 12697253 DOI: 10.1016/S1386-6346(02)00267-X]
49. Nishiguchi S, Habu D. Effect of oral supplementation with branched-chain amino acid granules in the early stage of cirrhosis. Hepatol Res 2004; 30S: 36-41 [PMID: 15607137 DOI: 10.1016/j.hepres.2004.08.009]
50. Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA, Ong TH, Lynch SV, Strong R. Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr 1992; 56: 158-163 [PMID: 1609753]
51. Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, Shiraishi K, Okuda H, Onji M, Kanazawa H, Tsubouchi H, Kato S, Kaito M, Watanabe A, Habu D, Ito S, Ishikawa T, Kawamura N, Arakawa Y. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007; 23: 113-120 [PMID: 17234504 DOI: 10.1016/j.nut.2006.10.008]
52. Ichikawa T, Naota T, Miyaaki H, Miuma S, Isomoto H, Takeshima F, Nakao K. Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance. Hepatol Res 2010; 40: 971-978 [PMID: 20887332 DOI: 10.1111/j.1872-034X.2010.00701.x]
53. Nakaya Y, Harada N, Kakui S, Okada K, Takahashi A, Inoi J, Ito S. Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acidenriched nutrient mixture. J Gastroenterol 2002; 37: 531-536 [PMID: 12162411 DOI: 10.1007/s005350200082]
54. Tsuchiya M, Sakaida I, Okamoto M, Okita K. The effect of a late evening snack in patients with liver cirrhosis. Hepatol Res 2005; 31: 95-103 [PMID: 15716064 DOI: 10.1016/ j.hepres.2004.11.009]
55. Kato M, Miwa Y, Tajika M, Hiraoka T, Muto Y, Moriwaki H. Preferential use of branched-chain amino acids as an energy substrate in patients with liver cirrhosis. Intern Med 1998; 37: 429-434 [PMID: 9652895 DOI: 10.2169/internalmedicine. 37.429]
56. Yamauchi M, Takeda K, Sakamoto K, Ohata M, Toda G. Effect of oral branched chain amino acid supplementation in the late evening on the nutritional state of patients with liver cirrhosis. Hepatol Res 2001; 21: 199-204 [PMID: 11673104 DOI: 10.1016/S1386-6346(01)00105-X]
57. Plauth M, Cabré E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, Ferenci P, Holm E, Vom Dahl S, Müller MJ, Nolte W. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006; 25: 285-294 [PMID: 16707194 DOI: 10.1016/ j.clnu.2006.01.018]
58. Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res 2010; 40: 8-13 [PMID: 20156296 DOI: 10.1111/j.1872-034X.2009.00634.x]
59. Bak LK, Iversen P, Sørensen M, Keiding S, Vilstrup H, Ott P, Waagepetersen HS, Schousboe A. Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. Metab Brain Dis 2009; 24: 135-145 [PMID: 19067142 DOI: 10.1007/ s11011-008-9123-4]
60. Nishikawa Y, Ukida M, Matsuo R, Morimoto Y, Omori N, Mikami M, Tsuji T. Administration of a branched-chain amino acid preparation during hepatic failure: a study emphasizing ammonia metabolism. Acta Med Okayama 1994; 48: 25-30 [PMID: 8191913]
61. Plauth M, Schütz T. Branched-chain amino acids in liver disease: new aspects of long known phenomena. Curr Opin Clin Nutr Metab Care 2011; 14: 61-66 [PMID: 21088568 DOI: 10.1097/MCO.0b013e3283413726]
62. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branchedchain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev 2003; (2): CD001939 [PMID: 12804416]
63. Kanematsu T, Koyanagi N, Matsumata T, Kitano S, Takenaka K, Sugimachi K. Lack of preventive effect of branchedchain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial. Surgery 1988; 104: 482-488 [PMID: 2842882]
64. Les I, Doval E, García-Martínez R, Planas M, Cárdenas G, Gómez P, Flavià M, Jacas C, Mínguez B, Vergara M, Soriano G, Vila C, Esteban R, Córdoba J. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Am J Gastroenterol 2011; 106: 1081-1088 [PMID: 21326220]
65. Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, Aagaard NK, Vilstrup H. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? Metab Brain Dis 2013; 28: 221-225 [PMID: 23275147 DOI: 10.1007/s11011-012-9372-0]
66. Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, Aagaard NK, Risum N, Vilstrup H. Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with metaanalyses of randomized controlled trials. J Nutr 2013; 143: 1263-1268 [PMID: 23739310]
67. Choudry HA, Pan M, Karinch AM, Souba WW. Branchedchain amino acid-enriched nutritional support in surgical and cancer patients. J Nutr 2006; 136: 314S-318S [PMID: 16365105]
68. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H, Ohashi Y. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006; 35: 204-214 [PMID: 16737844]
69. Kobayashi M, Ikeda K, Arase Y, Suzuki Y, Suzuki F, Akuta N, Hosaka T, Murashima N, Saitoh S, Someya T, Tsubota A, Kumada H. Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus. J Gastroenterol 2008; 43: 63-70 [PMID: 18297438]
70. Hayaishi S, Chung H, Kudo M, Ishikawa E, Takita M, Ueda T, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Ueshima K. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve eventfree survival in patients with liver cirrhosis. Dig Dis 2011; 29: 326-332 [PMID: 21829025]
71. Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Yamazaki M, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Morioka C, Fujimoto M, Uemura M, Fukui H. Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial. Oncol Rep 2011; 26: 1547-1553 [PMID: 21874260 DOI: 10.3892/ or.2011.1433]
72. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994; 331: 1547-1552 [PMID: 7969324]
73. Richter B, Schmandra TC, Golling M, Bechstein WO. Nutritional support after open liver resection: a systematic review. Dig Surg 2006; 23: 139-145 [PMID: 16809912]
74. Togo S, Tanaka K, Morioka D, Sugita M, Ueda M, Miura Y, Kubota T, Nagano Y, Matsuo K, Endo I, Sekido H, Shimada H. Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis. Nutrition 2005; 21: 480-486 [PMID: 15811769]
75. Ichikawa K, Okabayashi T, Maeda H, Namikawa T, Iiyama T, Sugimoto T, Kobayashi M, Mimura T, Hanazaki K. Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study. Surg Today 2013; 43: 720-726 [PMID: 22890582 DOI: 10.1007/s00595-012-0288-4]
76. Meng WC, Leung KL, Ho RL, Leung TW, Lau WY. Prospective randomized control study on the effect of branchedchain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg 1999; 69: 811-815 [PMID: 10553972]
77. Okabayashi T, Iyoki M, Sugimoto T, Kobayashi M, Hanazaki K. Oral supplementation with carbohydrate-and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Amino Acids 2011; 40: 1213-1220 [PMID: 20852905 DOI: 10.1007/s00726-010-0748-3]
78. Kuroda H, Ushio A, Miyamoto Y, Sawara K, Oikawa K, Kasai K, Endo R, Takikawa Y, Kato A, Suzuki K. Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial. J Gastroenterol Hepatol 2010; 25: 1550-1555 [PMID: 20796154]
79. Morihara D, Iwata K, Hanano T, Kunimoto H, Kuno S, Fukunaga A, Yotsumoto K, Takata K, Tanaka T, Sakurai K, Iwashita H, Ueda S, Hirano G, Yokoyama K, Nakane H, Nishizawa S, Yoshikane M, Anan A, Takeyama Y, Kakumitsu S, Kitamura Y, Sakamoto M, Irie M, Shakado S, Sohda T, Watanabe H, Sakisaka S. Late-evening snack with branched-chain amino acids improves liver function after radiofrequency ablation for hepatocellular carcinoma. Hepatol Res 2012; 42: 658-667 [PMID: 22380706 DOI: 10.1111/j.1872-034X.2012.00969.x]
80. Nishikawa H, Osaki Y, Iguchi E, Koshikawa Y, Ako S, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, Nasu A, Kita R, Kimura T. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation. J Clin Gastroenterol 2013; 47: 359-366 [PMID: 23090049 DOI: 10.1097/MCG.0b013e31826be9ad]
81. Poon RT, Yu WC, Fan ST, Wong J. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther 2004; 19: 779-788 [PMID: 15043519]
82. Takeshita S, Ichikawa T, Nakao K, Miyaaki H, Shibata H, Matsuzaki T, Muraoka T, Honda T, Otani M, Akiyama M, Miuma S, Ozawa E, Fujimito M, Eguchi K. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Nutr Res 2009; 29: 89-93 [PMID: 19285598 DOI: 10.1016/j.nutres.2008.12.005]
83. Nishikawa H, Osaki Y, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Henmi S, Sakamoto A, Ishikawa T, Saito S, Kita R, Kimura T. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2012; 18: 1379-1384 [PMID: 22493552 DOI: 10.3748/wjg.v18.i12.1379]
84. Lee IJ, Seong J, Bae JI, You SH, Rhee Y, Lee JH. Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study. Cancer Res Treat 2011; 43: 24-31 [PMID: 21509160 DOI: 10.4143/ crt.2011.43.1.24]
85. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr 2006; 136: 295S-298S [PMID: 16365102]
86. Kitagawa T, Yokoyama Y, Kokuryo T, Nagino M. Protective effects of branched-chain amino acids on hepatic ischemiareperfusion-induced liver injury in rats: a direct attenuation of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2013; 304: G346-G355 [PMID: 23275614 DOI: 10.1152/ ajpgi.00391.2012]
87. Deshpande G, Adachi N, Liu K, Motoki A, Mitsuyo T, Nagaro T, Arai T. Recovery of brain dopamine metabolism by branched-chain amino acids in rats with acute hepatic failure. J Neurosurg Anesthesiol 2007; 19: 243-248 [PMID: 17893576]
88. Kuwahata M, Kuramoto Y, Tomoe Y, Sugata E, Segawa H, Ito M, Oka T, Miyamoto K. Posttranscriptional regulation of albumin gene expression by branched-chain amino acids in rats with acute liver injury. Biochim Biophys Acta 2004; 1739: 62-69 [PMID: 15607118]
89. Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976; 6: 387-394 [PMID: 10164]
90. Rosen HM, Yoshimura N, Hodgman JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977; 72: 483-487 [PMID: 832796]
91. O'Shea RS, McCullough AJ. Treatment of alcoholic hepatitis. Clin Liver Dis 2005; 9: 103-134 [PMID: 15763232]
92. Arrese M, Riquelme A, Soza A. Insulin resistance, hepatic steatosis and hepatitis C: a complex relationship with relevant clinical implications. Ann Hepatol 2010; 9 Suppl: 112-118 [PMID: 20714007]
93. Kawaguchi T, Yamagishi S, Sata M. Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance. Curr Med Chem 2009; 16: 4843-4857 [PMID: 19929783]
94. Takeshita Y, Takamura T, Kita Y, Ando H, Ueda T, Kato K, Misu H, Sunagozaka H, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kaneko S. Beneficial effect of branched-chain amino acid supplementation on glycemic control in chronic hepatitis C patients with insulin resistance: implications for type 2 diabetes. Metabolism 2012; 61: 1388-1394 [PMID: 22520843 DOI: 10.1016/j.metabol.2012.03.011]
95. Honda M, Takehana K, Sakai A, Tagata Y, Shirasaki T, Nishitani S, Muramatsu T, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, Yamashita T, Nakamura M, Shimakami T, Yi M, Lemon SM, Suzuki T, Wakita T, Kaneko S. Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C. Gastroen-terology 2011; 141: 128-140, 140. e1-2 [PMID: 21458454 DOI: 10.1053/j.gastro.2011.03.051]
96. Kawaguchi T, Torimura T, Takata A, Satomi S, Sata M. Valine, a branched-chain amino Acid, reduced HCV viral load and led to eradication of HCV by interferon therapy in a decompensated cirrhotic patient. Case Rep Gastroenterol 2012; 6: 660-667 [PMID: 23185147 DOI: 10.1159/000343094]
97. Nagao Y, Kawaguchi T, Ide T, Sata M. Effect of branchedchain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study. Virol J 2012; 9: 282 [PMID: 23173649 DOI: 10.1186/1743-422X-9-282]
98. Kaido T, Mori A, Oike F, Mizumoto M, Ogura Y, Hata K, Yoshizawa A, Iida T, Uemoto S. Impact of pretransplant nutritional status in patients undergoing liver transplantation. Hepatogastroenterology 2010; 57: 1489-1492 [PMID: 21443108]
99. Kawamura E, Habu D, Morikawa H, Enomoto M, Kawabe J, Tamori A, Sakaguchi H, Saeki S, Kawada N, Shiomi S. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for preliver transplant status. Liver Transpl 2009; 15: 790-797 [PMID: 19562716 DOI: 10.1002/lt.21758]
100. Shirabe K, Yoshimatsu M, Motomura T, Takeishi K, Toshima T, Muto J, Matono R, Taketomi A, Uchiyama H, Maehara Y. Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. Liver Transpl 2011; 17: 1073-1080 [PMID: 21542128 DOI: 10.1002/lt.22324]
101. Kawaguchi T, Izumi N, Charlton MR, Sata M. Branchedchain amino acids as pharmacological nutrients in chronic liver disease. Hepatology 2011; 54: 1063-1070 [PMID: 21563202]
102. Tabaru A, Shirohara H, Moriyama A, Otsuki M. Effects of branched-chain-enriched amino acid solution on insulin and glucagon secretion and blood glucose level in liver cirrhosis. Scand J Gastroenterol 1998; 33: 853-859 [PMID: 9754734]
103. Korenaga K, Korenaga M, Uchida K, Yamasaki T, Sakaida I. Effects of a late evening snack combined with alphaglucosidase inhibitor on liver cirrhosis. Hepatol Res 2008; 38: 1087-1097 [PMID: 18647188]
104. Sakaida I, Tsuchiya M, Okamoto M, Okita K. Late evening snack and the change of blood glucose level in patients with liver cirrhosis. Hepatol Res 2004; 30S: 67-72 [PMID: 15607142]
105. Kawaguchi T, Taniguchi E, Itou M, Sumie S, Oriishi T, Matsuoka H, Nagao Y, Sata M. Branched-chain amino acids improve insulin resistance in patients with hepatitis C virusrelated liver disease: report of two cases. Liver Int 2007; 27: 1287-1292 [PMID: 17919242]
106. Miyake T, Abe M, Furukawa S, Tokumoto Y, Toshimitsu K, Ueda T, Yamamoto S, Hirooka M, Kumagi T, Hiasa Y, Matsuura B, Onji M. Long-term branched-chain amino acid supplementation improves glucose tolerance in patients with nonalcoholic steatohepatitis-related cirrhosis. Intern Med 2012; 51: 2151-2155 [PMID: 22892494]